Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie Legrand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Gene Therapy|August 23, 2002
Transductional targeting with recombinant adenovirus vectorsValerie Legrand, Philippe Leissner, Arend Winter, et al.
Neurosurgery|July 11, 2007
Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trialJ T Lindsay Wilson, Frans J A Slieker, Valerie Legrand, et al.
Microscopy Research and Technique|March 29, 2002
Adenovirus infection targets the cellular protein kinase CK2 and RNA-activated protein kinase (PKR) into viral inclusions of the cell nucleusSylvie Souquere-Besse, Evelyne Pichard, Odile Filhol, et al.
The Lancet. Neurology|December 20, 2005
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trialAndrew I R Maas, Gordon Murray, Herbert Henney, et al.
Neurosurgery|December 20, 2014
Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational studyAndrew I R Maas, David K Menon, Ewout W Steyerberg, et al.
BMC Medical Ethics|May 14, 2020
How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI studyMarjolein Timmers, Jeroen T J M van Dijck, Roel P J van Wijk, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Gene Therapy|August 23, 2002
Transductional targeting with recombinant adenovirus vectorsValerie Legrand, Philippe Leissner, Arend Winter, et al.
Neurosurgery|July 11, 2007
Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trialJ T Lindsay Wilson, Frans J A Slieker, Valerie Legrand, et al.
Microscopy Research and Technique|March 29, 2002
Adenovirus infection targets the cellular protein kinase CK2 and RNA-activated protein kinase (PKR) into viral inclusions of the cell nucleusSylvie Souquere-Besse, Evelyne Pichard, Odile Filhol, et al.
The Lancet. Neurology|December 20, 2005
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trialAndrew I R Maas, Gordon Murray, Herbert Henney, et al.
Neurosurgery|December 20, 2014
Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational studyAndrew I R Maas, David K Menon, Ewout W Steyerberg, et al.
BMC Medical Ethics|May 14, 2020
How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI studyMarjolein Timmers, Jeroen T J M van Dijck, Roel P J van Wijk, et al.
Pageof 1